From 1 January 2027, Eliquis® will no longer be reimbursed in Belgium. The medicine itself is not disappearing, and its active ingredient, apixaban, will be available as a reimbursed generic from 21 November 2026.
Eliquis® reimbursement ends in 2027
8 October 2026
by
Belgian Society of Cardiology vzw
in BSC news